Clinical and biological predictors of treatment-free remission in CML.
1/5 보강
Chronic Myeloid Leukemia (CML) is characterized by the Philadelphia chromosome t(9:22) and results in the fusion gene.
APA
Sutton E, Shanmuganathan N, Ross D (2025). Clinical and biological predictors of treatment-free remission in CML.. Leukemia & lymphoma, 66(14), 2578-2587. https://doi.org/10.1080/10428194.2025.2560081
MLA
Sutton E, et al.. "Clinical and biological predictors of treatment-free remission in CML.." Leukemia & lymphoma, vol. 66, no. 14, 2025, pp. 2578-2587.
PMID
41070556 ↗
Abstract 한글 요약
Chronic Myeloid Leukemia (CML) is characterized by the Philadelphia chromosome t(9:22) and results in the fusion gene. Since the evolution of targeted therapy in the form of tyrosine kinase inhibitors (TKIs), overall survival has improved to 94% at 5 years. Early studies identified that approximately half of patients could maintain a major molecular remission (MMR), i.e. ≤ 0.1%, in the absence of TKI therapy. This is termed treatment-free remission (TFR). Identifying clinical and biological predictors of TFR has become a major goal in CML. In this review, we discuss clinical predictors of TFR, including features at diagnosis, molecular response and kinetics, depth and duration of molecular response, and dose reduction prior to TKI cessation in determining TFR success. We also discuss advances in highly sensitive Minimal Residual Disease (MRD) assays, consider the genomic profile of CML patients and review the role of the immune environment in sustaining TFR.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.